DarioHealth Receives Bullish Rating with $3 Price Target, Signaling Potential 350% Growth
Litchfield Hills Research initiates a Buy rating for DarioHealth, projecting substantial growth potential based on the company's strategic B2B2C transformation, multi-condition digital health platform, and strong market positioning in chronic care management.
